Heid, have agreed to pay $400,000 in consumer redress to settle FTC charges that they deceptively marketed a purported weight-loss pill called Himalayan Diet Breakthrough
For men who strongly prefer pills over needles, this convenience factor weighs heavily
Compared to the other trials investigating GLP-1RAs, the ELIXA trial included T2D patients with recent acute coronary syndrome (ACS), suggesting that perhaps their CV risk was too severe to demonstrate a simple decline in CV events via short-term pharmacological intervention
Spacing out dose frequency The Approach Spaced out dosing means extending the interval between GLP-1 injections beyond the approved schedule (for example, taking a weekly medicine less often than once a week)
The ongoing development of novel agents, including the GLP-1/glucagon dual receptor agonist maxadutide and the exploration of triple receptor agonists, continues to expand treatment options